“…Available data, in 2001,
indicated that resistance to isometamidium was more widespread than resistance to diminazene
(Geerts et al
2001), however, this may no longer be so, as
prevalence of resistance may change substantially over a few years (Delespaux et al
2008 a ). Treatment failure against
T. congolense and T. vivax infections with either of
these drugs has been observed in both West (Kupper and Wolters, 1983; Pinder and Authie, 1984; Knoppe et al
2006; Mungube et al
2012; Vitouley et al
2012) and East Africa (Mbwambo et al
1988; Chitambo and Arakawa, 1992 a ; Dagnachew et al
2015; Moti et al
2015). More worryingly, strains of T.
congolense resistant to both isometamidium and diminazene have been detected in
several locations, including Cameroon (Mamoudou et al
2008), Burkina Faso (Clausen et al
1992), Ethiopia (Codjia et al
1993; Afewerk et al
2000; Moti et al
2012), Somalia (Ainanshe et al
1992) and Zambia (Sinyangwe et al
2004), rendering their use as a sanative pair
inoperative.…”